CME Group Inc. - (CME): Price and Financial Metrics
CME Group Inc. - (CME)
Today's Latest Price: $180.49 USD
Updated May 28 4:00pm
Add CME to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 5 in Financial Marketplaces
See all "A" rated Strong Buy stocks
CME Stock Summary
- CME has a market capitalization of $63,301,267,960 -- more than approximately 97.23% of US stocks.
- For CME, its debt to operating expenses ratio is greater than that reported by 98.17% of US equities we're observing.
- In terms of volatility of its share price, CME is more volatile than only 6.45% of stocks we're observing.
- Stocks that are quantitatively similar to CME, based on their financial statements, market capitalization, and price volatility, are BNS, GS, MUFG, BCS, and WBK.
- Visit CME's SEC page to see the company's official filings. To visit the company's web site, go to www.cmegroup.com.
CME Stock Price Chart More Charts
CME Price/Volume Stats
| Current price | $180.49 | 52-week high | $225.36 |
| Prev. close | $176.53 | 52-week low | $131.80 |
| Day low | $176.08 | Volume | 2,393,903 |
| Day high | $182.28 | Avg. volume | 2,174,887 |
| 50-day MA | $176.21 | Dividend yield | 1.93% |
| 200-day MA | $199.69 | Market Cap | 64.72B |
CME Group Inc. - (CME) Company Bio
CME Group operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products for trading and/or clearing across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. The company was founded in 1898 and is based in Chicago, Illinois.
CME Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $180.49 | $212.29 | 20% |
We started the process of determining a valid price forecast for Cme Group Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cme Group Inc ranked in the 53th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 20.83%. The most interesting components of our discounted cash flow analysis for Cme Group Inc ended up being:
- The company's balance sheet shows it gets 38% of its capital from equity, and 62% of its capital from debt. Its equity weight surpasses that of merely 19.09% of free cash flow generating stocks in the Financial Services sector.
- Cme Group Inc's weighted average cost of capital (WACC) is 5%; for context, that number is higher than only 1.23% of tickers in our DCF set.
- CME's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than only 1.23% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 18% |
| 1% | 19% |
| 2% | 20% |
| 3% | 21% |
| 4% | 23% |
| 5% | 24% |
CINF, SPGI, CNA, BRK.B, and FSAM can be thought of as valuation peers to CME, in the sense that they are in the Financial Services sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...